CDK11 expression was not correlated with the breast cancer patients’ menopausal status, tumor size, HER-2 status, differentiation or TNM status, but was negatively correlated with age, node status, ER, relapse and metastasis status (P < 0.05). Here, CDK11B is linked to breast carcinoma.